Belgie - nizozemština - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

b. braun melsungen ag - kaliumchloride 0,4 mg/ml; natriumchloride 6 mg/ml; natriumlactaat 3,12 mg/ml; calciumchloridedihydraat 0,27 g/1000 ml - oplossing voor infusie - kaliumchloride 0.4 mg/ml; natriumlactaat 3.12 mg/ml; natriumchloride 6 mg/ml; calciumchloridedihydraat - electrolytes

Finsko - finština - Fimea (Suomen lääkevirasto)

b. braun melsungen ag - kalii chloridum,glukoosi monohydricum - infuusioneste, liuos - 3 mg/ml + 50 mg/ml - elektrolyytit ja hiilihydraatit

Finsko - finština - Fimea (Suomen lääkevirasto)

b. braun melsungen ag - kalii chloridum,glukoosi monohydricum - infuusioneste, liuos - 1.5 mg/ml + 50 mg/ml - elektrolyytit ja hiilihydraatit

Nizozemsko - nizozemština - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

b. braun melsungen ag (melsungen) carl-braun-strasse 1 34212 melsungen (duitsland) - mepivacainehydrochloride 10 mg/ml - oplossing voor injectie - natriumchloride ; natriumhydroxide (e 524) ; water, gezuiverd, - mepivacaine

Řecko - řečtina - Εθνικός Οργανισμός Φαρμάκων

b. braun melsungen a.g, germany carl-braun-strasse 1, 34212 melsungen 0049 56 61 71 2849 - isoleucine; leucine; lysine hydrochloride; methionine; phenylalanine; threonine; tryptophan, l-; valine; arginine; histidine; alanine; glycine; aspartic acid; glutamic acid; proline; serine; tyrosine; sodium acetate trihydrate; sodium hydroxide; potassium acetate; magnesium chloride hexahydrate; sodium phosphate dibasic dodecahydrate - sol.inf (ΔΙΑΛΥΜΑ ΓΙΑ ΕΓΧΥΣΗ) - 10% - isoleucine 5g; leucine 8,9g; lysine hydrochloride 8,56g; methionine 4,4g; phenylalanine 4,7g; threonine 4,2g; tryptophan, l- 1,6g; valine 6,2g; arginine 11,5g; histidine 3g; alanine 10,5g; glycine 12g; aspartic acid 5,6g; glutamic acid 7,2g; proline 5,5g; serine 2,3g; tyrosine 0,4g; sodium acetate trihydrate 2,858g; sodium hydroxide 0,36g; potassium acetate 2,453g; magnesium chloride hexahydrate 0,508g; sodium phosphate dibasic dodecahydrate 3,581g - amino acids

Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

fresenius kabi s.r.o., praha array - 14768 sukcinylovanÁ Želatina; 1322 chlorid sodnÝ; 856 hexahydrÁt chloridu hoŘeČnatÉho; 1174 chlorid draselnÝ; 13184 roztok natrium-laktÁtu 50% - infuzní roztok - ŽelatinovÉ pŘÍpravky

Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

fresenius kabi s.r.o., praha array - 1322 chlorid sodnÝ; 1174 chlorid draselnÝ; 5599 dihydrÁt chloridu vÁpenatÉho; 1334 natrium-laktÁt - infuzní roztok - elektrolyty

Spojené státy - angličtina - NLM (National Library of Medicine)

b. braun medical inc. - hydroxyethyl starch 130/0.4 (unii: 1gvo236s58) (hydroxyethyl starch 130/0.4 - unii:1gvo236s58), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - hydroxyethyl starch 130/0.4 6 g in 100 ml - 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection is indicated for the treatment and prophylaxis of hypovolemia in adults and children. it is not a substitute for red blood cells or coagulation factors in plasma. - do not use hydroxyethyl starch (hes) products, including 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection, in critically ill adult patients, including patients with sepsis, due to increased risk of mortality and renal replacement therapy (rrt).  - do not use hes products, including 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection, in patients with severe liver disease. - do not use hes products, including 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection, in patients with known hypersensitivity to hydroxyethyl starch [see general warnings and precautions (5.1) ] - do not use hes products in clinical conditions with volume overload.  - do not use hes products in patients with pre-existing coagulation or bleeding disorders.  - do not use h

Spojené státy - angličtina - NLM (National Library of Medicine)

fresenius kabi usa, llc - diphenhydramine hydrochloride (unii: tc2d6jad40) (diphenhydramine - unii:8gts82s83m) - diphenhydramine hydrochloride 50 mg in 1 ml - diphenhydramine hydrochloride in the injectable form is effective in adults and pediatric patients, other than premature infants and neonates, for the following conditions when diphenhydramine hydrochloride in the oral form is impractical. antihistaminic: for amelioration of allergic reactions to blood or plasma, in anaphylaxis as an adjunct to epinephrine and other standard measures after the acute symptoms have been controlled, and for other uncomplicated allergic conditions of the immediate type when oral therapy is impossible or contraindicated. motion sickness: for active treatment of motion sickness. antiparkinsonism: for use in parkinsonism, when oral therapy is impossible or contraindicated, as follows: parkinsonism in the elderly who are unable to tolerate more potent agents; mild cases of parkinsonism in other age groups, and in other cases of parkinsonism in combination with centrally acting anticholinergic agents. use in neonates or premature infants: this drug should not be used

Spojené státy - angličtina - NLM (National Library of Medicine)

b. braun medical inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838), sodium acetate (unii: 4550k0sc9b) (sodium cation - unii:lyr4m0nh37), sodium citrate (unii: 1q73q2julr) (sodium cation - unii:lyr4m0nh37) - sodium chloride 6.4 mg in 1 ml - for use as an extraocular and intraocular irrigating solution during ocular surgical procedure involving perfusion of the eye with an expected maximum duration of less than 60 minutes.